The permanent injunction granted by the District of Delaware in the dispute between Amgen and Sanofi/Regeneron over cholesterol-lowering treatment has been vacated, in a decision that also included some implications for the USPTO’s practice of granting broad antibody claims
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The court, which has handed down one of the highest ever IP damages awards in India, held Amazon liable for infringing the 'Beverly Hills Polo Club' trademark
Exclusive data and analysis reveal the interplay between costs transparency and other factors in helping South African counsel pick their external advisers